Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case
Abstract Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema. In this study, we discuss a case of a 1-year-old child diagnosed with refractory visceral leishmaniasis after being treated with liposomal amphotericin B in two distinct occasions. Considering the persistent clinical features and weak response to conventional treatment, a combination therapy with liposomal amphotericin B (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate was initiated, and response to treatment was good.
Main Authors: | , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical - SBMT
2018
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000300393 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0037-86822018000300393 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0037-868220180003003932018-12-04Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis caseGomes,Maria Antonia FerreiraMedeiros,Lana Lira Cantidio deLobo,Fernanda Paula DantasWanderley,Nathália Rayane SilvaMatos,Ana Paula RodriguesJácome,Tácito do NascimentoMonteiro,Maria Goretti LinsLuz,Kleber Giovanni Visceral leishmaniasis Refractory Treatment Abstract Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema. In this study, we discuss a case of a 1-year-old child diagnosed with refractory visceral leishmaniasis after being treated with liposomal amphotericin B in two distinct occasions. Considering the persistent clinical features and weak response to conventional treatment, a combination therapy with liposomal amphotericin B (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate was initiated, and response to treatment was good.info:eu-repo/semantics/openAccessSociedade Brasileira de Medicina Tropical - SBMTRevista da Sociedade Brasileira de Medicina Tropical v.51 n.3 20182018-06-01info:eu-repo/semantics/reporttext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000300393en10.1590/0037-8682-0398-2017 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Gomes,Maria Antonia Ferreira Medeiros,Lana Lira Cantidio de Lobo,Fernanda Paula Dantas Wanderley,Nathália Rayane Silva Matos,Ana Paula Rodrigues Jácome,Tácito do Nascimento Monteiro,Maria Goretti Lins Luz,Kleber Giovanni |
spellingShingle |
Gomes,Maria Antonia Ferreira Medeiros,Lana Lira Cantidio de Lobo,Fernanda Paula Dantas Wanderley,Nathália Rayane Silva Matos,Ana Paula Rodrigues Jácome,Tácito do Nascimento Monteiro,Maria Goretti Lins Luz,Kleber Giovanni Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case |
author_facet |
Gomes,Maria Antonia Ferreira Medeiros,Lana Lira Cantidio de Lobo,Fernanda Paula Dantas Wanderley,Nathália Rayane Silva Matos,Ana Paula Rodrigues Jácome,Tácito do Nascimento Monteiro,Maria Goretti Lins Luz,Kleber Giovanni |
author_sort |
Gomes,Maria Antonia Ferreira |
title |
Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case |
title_short |
Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case |
title_full |
Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case |
title_fullStr |
Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case |
title_full_unstemmed |
Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case |
title_sort |
combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case |
description |
Abstract Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema. In this study, we discuss a case of a 1-year-old child diagnosed with refractory visceral leishmaniasis after being treated with liposomal amphotericin B in two distinct occasions. Considering the persistent clinical features and weak response to conventional treatment, a combination therapy with liposomal amphotericin B (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate was initiated, and response to treatment was good. |
publisher |
Sociedade Brasileira de Medicina Tropical - SBMT |
publishDate |
2018 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000300393 |
work_keys_str_mv |
AT gomesmariaantoniaferreira combinationtherapywithliposomalamphotericinbambisomenmethylglucamineantimoniateglucantimeandpentamidineisethionateinarefractoryvisceralleishmaniasiscase AT medeiroslanaliracantidiode combinationtherapywithliposomalamphotericinbambisomenmethylglucamineantimoniateglucantimeandpentamidineisethionateinarefractoryvisceralleishmaniasiscase AT lobofernandapauladantas combinationtherapywithliposomalamphotericinbambisomenmethylglucamineantimoniateglucantimeandpentamidineisethionateinarefractoryvisceralleishmaniasiscase AT wanderleynathaliarayanesilva combinationtherapywithliposomalamphotericinbambisomenmethylglucamineantimoniateglucantimeandpentamidineisethionateinarefractoryvisceralleishmaniasiscase AT matosanapaularodrigues combinationtherapywithliposomalamphotericinbambisomenmethylglucamineantimoniateglucantimeandpentamidineisethionateinarefractoryvisceralleishmaniasiscase AT jacometacitodonascimento combinationtherapywithliposomalamphotericinbambisomenmethylglucamineantimoniateglucantimeandpentamidineisethionateinarefractoryvisceralleishmaniasiscase AT monteiromariagorettilins combinationtherapywithliposomalamphotericinbambisomenmethylglucamineantimoniateglucantimeandpentamidineisethionateinarefractoryvisceralleishmaniasiscase AT luzklebergiovanni combinationtherapywithliposomalamphotericinbambisomenmethylglucamineantimoniateglucantimeandpentamidineisethionateinarefractoryvisceralleishmaniasiscase |
_version_ |
1756380627738820608 |